from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Blanket Consent filed by Petitioner, Amgen Inc., et al.
Blanket Consent filed by Respondent, Sanofi, et al.
Petition GRANTED limited to Question 2 presented by the petition.
Supplemental brief of petitioners Amgen Inc., et al. filed. (Distributed)
Brief amicus curiae of United States filed.
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Reply of petitioners Amgen Inc., et al. filed. (Distributed)
Brief of respondents Sanofi, et al. in opposition filed.
Motion to extend the time to file a response is granted and the time is extended to and including March 14, 2022.
Motion to extend the time to file a response from February 10, 2022 to March 14, 2022, submitted to The Clerk.
Response Requested. (Due February 10, 2022)
Brief amicus curiae of GlaxoSmithKline plc filed.
Brief amici curiae of Intellectual Property Professors filed.
Brief amici curiae of Association of University Technology Managers, Inc., et al.
Petition for a writ of certiorari filed. (Response due December 22, 2021)
Amgen Inc., et al., Petitioner, represented by Jeffrey Alan Lamken
Sanofi, et al., Respondent, represented by George William Hicks Jr.
Association of University Technology Managers, Inc., Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, Merck Sharp & Dohme Corp., and St. Jude Children’s Research Hospital, Inc., Amicus Curiae, represented by Jeffrey P. Kushan
GlaxoSmithKline plc, Amicus Curiae, represented by John M. Desmarais
Intellectual Property Professors, Amicus Curiae, represented by Mark A. Lemley
United States, Amicus Curiae, represented by Elizabeth B. Prelogar